Global Single Cell Multiomics Market

According to the latest report by IMARC Group, titled Single Cell Multiomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the global single cell multiomics market reached a value of US$ 2.85 Billion in 2021. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 7.73 Billion by 2027, growing at a CAGR of 17.30% during 2022-2027.

Single cell multiomics refers to an advanced analytical technology that examines and isolates multiple types of molecules from similar individual cells. This, in turn, assists in gaining extensive biological insight regarding cellular properties and architecture of heterogeneous tissues. Apart from this, single cell multiomics aids in analyzing the genome, epigenome, metabolome lineages, transcriptome, and proteome, which are further utilized in cell biology, oncology, immunotherapy, and neurological applications. It relies on isolation and dispensing methodologies for providing images of various molecular layers and complex biological structures. As compared to conventional live-cell fluorescence imaging techniques, single cell multiomics does not destroy cells for assessment purposes and measures multiple types of molecules from a single cell. On account of these properties, it is widely used in hospitals, biotech companies and pharmaceutical organizations.

Request for a PDF sample of this report:

Global Single Cell Multiomics Market Trends/Drivers:

The global single cell multiomics market is primarily driven by the increasing prevalence of various lifestyle and communicable diseases, especially amongst the geriatric population. This, in turn, has facilitated the widespread adoption of single cell multiomics across pharmaceutical companies, academic institutions and hospitals for antibody discovery purposes and gaining a high-resolution landscape of cellular components present in the tumor. Additionally, rapid expansion in the healthcare sector and the rising need for personalized medicine and solutions for screening and diagnosing genetic disorders and cell heterogeneity in the micro-environment is acting as another growth-inducing factor. In line with this, significant technological advancements, such as the introduction of barcoding and single-cell multimodal omics (scMulti-omics) solutions, are contributing to the market growth. These systems help in measuring multiple resolutions from similar cells, including chromatin accessibility, messenger ribonucleic acid (mRNA) and deoxyribonucleic acid (DNA). Other factors, such as strategic collaborations amongst key players and continuous investments in the research and development (R&D) activities in the field of medical sciences to introduce single-cell analysis products, are creating a positive outlook for the market.

Checkout Now:

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global single cell multiomicsmarket, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, product type, technique, application and end user.

Competitive Landscape:

  • 10x Genomics Inc
  • Becton Dickinson and Company
  • BGI Genomics (BGI Group)
  • Bio-RAD Laboratories Inc.
  • Fluidigm Corporation
  • Illumina Inc
  • Mission Bio
  • NanoCellect Biomedical
  • Nanostring Technologies Inc
  • Proteona, Takara Bio Inc.
  • Takara Holdings
  • Thermo Fisher Scientific Inc.

Breakup by Type:

  • Single Cell Genomics
  • Single Cell Proteomics
  • Single Cell Transcriptomics
  • Single Cell Metabolomics

Breakup by Product Type:

  • Consumables
  • Instruments
  • Software

Breakup by Technique:

  • Single-Cell Isolation and Dispensing
  • Single-Cell Analysis

Breakup by Application:

  • Oncology
  • Cell Biology
  • Neurology
  • Others

Breakup by End User:

  • Academic Institutes
  • Contract Research Organizations
  • Pharmaceutical and Biotech Companies

Breakup by Region:

Ask Analyst for Customization and Explore full report with TOC & List of Figures

Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:                                                           

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us                                                                     

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Leave a Reply

Your email address will not be published. Required fields are marked *

5 − five =